Follow us on Twitter
twitter icon@FreshPatents


Anesthetic patents

      

This page is updated frequently with new Anesthetic-related patent applications.




 Introduced in adsorption filter for inhaled halogenated anesthetics for cardiopulmonary circulation bypass patent thumbnailIntroduced in adsorption filter for inhaled halogenated anesthetics for cardiopulmonary circulation bypass
Improvements introduced in adsorption filter for inhaled halogenated anesthetics for cardiopulmonary bypass. It relates to an adsorption filter (10) of the type pertaining to the field of medical devices, more specifically, used to adsorb inhaled halogenated anesthetics that are eliminated through the output of the membrane oxygenators (20) of the cardiopulmonary bypass circuit (cpb); said filter (10) contains a hollow reservoir (11) for preservation of adsorber elements (ed) of the activated charcoal type (30), said reservoir (11) being of tubular cylindrical form, and it receives on one of the free extremities (11a) a cover (12) whose internal diameter (d1) is greater than the external diameter (d2) of the cylindrical reservoir (11), so as to produce an access chamber (c1) for the input of the inhaled anesthetic (al) that, in turn, penetrates through a tubular member (12a) in the central portion of the cover (12), where a tube (tb1) for connection with the oxygenator device (20) is installed, said tube (tb1) allowing the input of the gas (al) into the filter (10) for decontamination; on the same extremity (11a) and in the peripheral wall (11b) are made openings (11c) intended for the input of the inhaled anesthetic (al) after input in the chamber (c1), initiating the ingression in the chamber (c2) of the cylinder (11) endowed with adsorber element (ed)..
Copeen Treinamento E Consultoria Em Anestesia Eireli


 Topical herpes pain treatment and composition patent thumbnailTopical herpes pain treatment and composition
The present invention is the treatment of herpes simplex virus lesion pain via application of a product containing a quick acting and long acting topical anesthetic.. .

 Bioabsorbable tissue support adjunctive to tissue piercing patent thumbnailBioabsorbable tissue support adjunctive to tissue piercing
A bioabsorbable tissue support is inserted into a tissue of a subject during, or after, puncture of the tissue. The bioabsorbable tissue support includes a material that is gradually absorbed into the punctured tissue in time, and disappears.

 Methods and kits for treating dysmotility patent thumbnailMethods and kits for treating dysmotility
Described herein are methods and kits for treating dysmotility. Certain methods for treating dysmotility involve delivering a local anesthetic to at least one of the greater, lesser or least splanchnic nerves of a patient having dysmotility, or to the celiac plexus of the patient having dysmotility, to thereby reduce symptoms of dysmotility.

 Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs patent thumbnailFluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs
The present invention provides therapeutic formulations, including therapeutic nanoemulsions, and related methods for the in vivo delivery of hydrophobic compounds, including an important class of hydrophobic anesthetics. Formulations and methods of the invention include semifluorinated block copolymers, and optionally phospholipid surfactants, capable of forming a stable nanoemulsion without the need of conventional lipid components that support bacterial and/or fungal growth (e.g., soybean oil and similar lipids).
Wisconsin Alumni Research Foundation


 Neuroactive 13, 17-substituted steroids as modulators for gaba type-a receptors patent thumbnailNeuroactive 13, 17-substituted steroids as modulators for gaba type-a receptors
The present disclosure is generally directed to neuroactive 13, 17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
Washington University


 Long-acting polymeric delivery systems patent thumbnailLong-acting polymeric delivery systems
Compositions comprised of a delivery vehicle or delivery system and an active agent dispersed within the delivery vehicle or system, wherein the delivery vehicle or system contains a polyorthoester polymer and a polar aprotic solvent. Also disclosed are low viscosity delivery systems for administration of active agents.
Heron Therapeutics, Inc.


 Long-acting polymeric delivery systems patent thumbnailLong-acting polymeric delivery systems
Compositions comprised of a delivery vehicle or delivery system and an active agent dispersed within the delivery vehicle or system, wherein the delivery vehicle or system contains a polyorthoester polymer and a polar aprotic solvent. Also disclosed are low viscosity delivery systems for administration of active agents.
Heron Therapeutics, Inc.


 Topical analgesic lotion patent thumbnailTopical analgesic lotion
Technologies are described for a formulation and production of a formulation. The methods may comprise depositing a non-steroidal anti-inflammatory drug (nsaid) compound into a chamber.
Synergistic Therapeutics, Llc


 Composition for improving the appearance of ageing skin patent thumbnailComposition for improving the appearance of ageing skin
A liquid composition for improving the facial contour and shape of the human or animal face by injection, the liquid composition comprising water and at least one of the following components a, b and c: at least one component a, which leads to an osmotic concentration in the range from 500 to 5000 mosm in the liquid composition, at least one high viscosity component b, which leads to a viscosity of the liquid composition in the range from 10 to 1500 mpas, at least one micro-particles component c, comprising micro-particles with an average particle size not larger than 0.25 mm, preferably in the range of 0.001 mm to 0.25 mm, and optionally comprising a local anesthetic compound d.. .
Merz Pharma Gmbh & Co. Kgaa


Iontophoresis methods

A method of anesthetizing a tympanic membrane of an ear of a patient using iontophoresis is disclosed. The method involves delivering an anesthetizing drug solution to an ear canal of the patient's ear, wherein the drug solution includes an anesthetic and a buffer, and wherein the drug solution has a ph in the range of about 6.5 to about 7.5; and applying an amount of current to the drug solution, wherein the amount of applied current is increased at a rate of less than about 0.5 milliamp per second until a maximum current is achieved..
Tusker Medical, Inc.

Improved instrument, article and minimizing pain

An instrument is described for minimizing pain during administration by injection of a liquid, such as, an anesthetic. The instrument includes a main body having a rod mounted freely for vibration and a single use tip removably mounted on the forward end of the main body by a first type of motion and removable by a second and different type of motion.
Bing Innovations Llc

Analgesic compositions and methods of use

The invention relates to the fields of pharmacology and medicine, and provides anesthetic compositions and methods for the treatment of pain using compositions comprising tea tree oil and one or more additional agent. The invention relates to analgesic compositions for the treatment of pain associated with a variety of disorders or conditions, particularly oral or dental disorders or conditions such as alveolar osteitis or dental caries..

Novel formulations of volatile anesthetics and methods of use for reducing inflammation

The present invention provides methods for treating inflammation or a wound in a subject in need of such wound treatment or inflammation treatment by delivering a volatile anesthetic to the wound or the inflammation site.. .
Board Of Regents, The University Of Texas System

High concentration local anesthetic formulations

A transdermal topical anesthetic formulation, which can be used to ameliorate or inhibit pain, has been developed. In the preferred embodiment, the topical anesthetic is a local anesthetic such as lidocaine, most preferably lidocaine free-base in a gel, and the dosage of the local anesthetic is effective in the painful area or immediately adjacent areas, to ameliorate or eliminate the pain.
Centrexion Therapeutics Corporation

Methods for treatment of pelvic pain and/or comorbid conditions

Methods, systems, devices, and medicaments are provided for locally administering to a pelvic-area organ or tissue structure in a patient at least one drug continuously or continually over a treatment period of 24 hours or more in an amount effective to achieve a therapeutic effect in another organ or tissue structure by means of shared or convergent pelvic afferent pathways. The methods systems, devices, and medicaments can be used in the treatment of ic/bps, chronic pelvic pain, vulvodynia, orchialgia, urethral syndrome, dysparenia, chronic prostatitis, chronic pelvic pain, levator ani syndrome, irritative bowel syndrome, or a combination thereof.
Allergan, Inc.

N-substituted imidazole carboxylic ester chiral compound containing an ether side chain, its preparation and application

The present invention relates to an n-substituted imidazole carboxylic ester chiral compound containing an ether side chain and to its preparation and application. The structure of this compound is represented by formula (i).
West China Hospital, Sichuan University

Long-acting polymeric delivery systems

Compositions comprised of a delivery vehicle or delivery system and an active agent dispersed within the delivery vehicle or system, wherein the delivery vehicle or system contains a polyorthoester polymer and a polar aprotic solvent. Also disclosed are low viscosity delivery systems for administration of active agents.
Heron Therapeutics, Inc.

Topical composition for pain relief

The composition comprises 0.5% to 10% by weight of a neuropathic analgesic; 0.5% to 10% by weight of a muscle relaxant; 0.5% to 20% by weight of an anti-inflammatory analgesic; and 0.5% to 10% by weight of an anesthetic.. .

Rescue inhaler

A portable rescue inhaler having a first canister containing a gas mixture of helium, oxygen, and nitrogen, and having a second canister containing an aerosolized medicine. The gas mixture of helium, oxygen, and nitrogen contained in the first canister has a density slightly lower than the density of atmospheric air.

Local anesthetic solution for dental and/or contrast media use

An improved local anesthetic solution with diminished bitter taste includes an anesthetic agent, an anesthetic solution vehicle, and a bitterness suppressant. The bitterness suppressant includes one or more compounds selected from the group consisting of: a sugar selected from the group consisting of monosaccharide sugars, disaccharide sugars, polysaccharide sugars, and combinations of the any of the foregoing; sweet-tasting compounds; acids; amino acids; salts; miscellaneous suppressant substances; and combinations of any of the foregoing.
Real Time Imaging Technologies, Llc

Device for treating truncal and/or collateral varicose veins and a synergistic physio-chemical use

A device for treating truncal and/or collateral varicose veins, such that they may be treated fully at outpatient clinics, without the need to use local anesthetic, wherein the device links the energy or power flow emitted by the laser to the effect of the sclerosant foam and, using a method which links the physio-chemical properties of the two synergistically, removes the exceptional venous endothelium, in addition to reducing both the concentration of the sclerosant substance and that of the energy released by the laser into the vein/varicose vein, such that the entire method may be carried out fully at outpatient clinics and performed in the usual work area, without the need for a strict surgical environment or local anesthetic, with the exception of the same being used at the entry point, it not being necessary to administer local anesthetic in a perivenous, tumescent and/or truncal way.. .

Infusion set with anesthetic compound

A method of constructing an infusion set, patch pump, or element thereof, comprising the steps of mixing at least two of a solvent, an anesthetic, and a lubricant, applying said mixture as a coating to at least one surface of an infusion set, patch pump, or element thereof, and substantially removing said solvent after coating to provide at least one of an anesthetic layer and a lubricant layer upon said infusion set, patch pump, or element thereof.. .
Becton, Dickinson And Company

Apparatus and the treatment of stress urinary incontinence

An apparatus and method for the treatment of stress urinary incontinence. The apparatus includes a suburethral sling having an adjustment member for adjusting the tension of the sling both during the procedure and post-procedure.
Boston Scientific Scimed, Inc.

Syringe actuator system for delivering toxic medical compositions

A system for dispensing botox, anti-venom, local chemotherapy, anesthetics, aesthetic fillers, endogen materials, fat for aesthetic surgery, stem cells, and lethal injection compounds though a sterile syringe. They system uses pressure, generated by a pump unit, to apply force on a syringe containing the materials to be delivered into the patient's body.
Alps South, Llc

Compositions comprising at least one polyol and at least one anesthetic

An injectable sterilized aqueous composition including at least one hyaluronic acid, at least one polyol and at least one local anesthetic chosen from the group made of benzocaine, chloroprocaine, procaine, etidocaine, aptocaine, chlorobutanol, diamocaine, dyclonine, guafecainol, polidocanol, mepivacaine, prilocaine, articaine, bupivacaine, ropivacaine, tetracaine and salts thereof and isolated isomers thereof. The invention also relates to a process for adapting the rheological properties of a heat sterilized injectable aqueous composition.
Laboratoires Vivacy

Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for gaba type-a receptors

The present disclosure is generally directed to neuroactive substituted cyclopenta[b]phenanthrenes as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to gaba function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds..
Washington University

Cassette assembly for syringe fill system

A syringe fill system is described, which is useful for filling syringes for dental anesthetic applications. The system incorporates capability for “push-pull”, “pull-push”, “push-push”, and “pull-pull” modes of operation, for loading syringes with compositions comprising multiple fluid components.
Anutra Medical, Inc.

Syringe fill system and method

A syringe fill system is described, which is useful for filling syringes for dental anesthetic applications. The system incorporates capability for “push-pull”, “pull-push”, “push-push”, and “pull-pull” modes of operation, for loading syringes with compositions comprising multiple fluid components.
Anutra Medical, Inc.

Coupler for safe delivery of anesthesia gases

A breathing circuit delivers anesthetic gases to a patient. The breathing circuit includes a hose having a proximal end coupled to an anesthetic gas delivery machine and a distal end, a breathing apparatus attached to a patient to facilitate patient inhalation and a coupler having a proximal end connected to the distal end of the hose and a distal end connected to the breathing apparatus.
Veranos, Inc.

Method and pharmaceutical to treat spinal discs

Methods for reducing chronic pain caused by a disrupted spinal disc are described. In one method, a solution is injected into the disc.

Topical medications for bruises and burns

Topical medications to treat the physical effects of bruises and burns. For bruises, the topical medication preferably includes therapeutically effective amounts of vasoconstrictor, such as phenylephrine hcl usp, an anti-inflammatory, such as arica, and compounding agents.
Meridian Research And Development, Inc.

Methods of inducing sedation

The present invention provides methods for determining the selectivity of a sedative for an anesthetic-sensitive receptor by determining the molar water solubility of the sedative. The invention further provides methods for modulating the selectivity of a sedative for an anesthetic-sensitive receptor by altering or modifying the sedative to have higher or lower water solubility.
The Regents Of The University Of California

Method for treating angina

A method for treating angina by introducing medicine to a patient's sphenopalatine ganglion with a catheter. The medicine includes a mixture of a local anesthetic, a steroid, an analgesic and an anti-inflammatory..
Nogina, Llc

Method and applying an anesthetic and bactericide

A method and an apparatus for applying an anesthetic includes a receptacle having an upper end, a substantially hollow interior, a lower end having a tube or nozzle extending therefrom, and an attachment for attaching to the barrel of a syringe or vice versa. The receptacle receives a container or canister containing an endothermic gas or vapor (propellant) that rapidly absorbs heat when released to the atmosphere.
Leibovici Llc

Assembly for sequentially percutaneously applying an electrode and an anesthetic to tissue

An assembly that consist of a cannula; an electrode and a syringe. The cannula has a hub that defines a set of adjacent bores.
Stryker Corporation

Apparatus and electroencephalographic examination

An apparatus comprises a data processing unit (100) which receives electroencephalographic data based on a measurement of a person (110) exposed to anesthetic drug substance which has one or more estimated or measured non-zero levels of concentration in the body (108) of the person (110) as a function of time; and determines and present activity of slow waves of the electroencephalographic data at the one or more estimated or measured levels of the non-zero concentration of the anesthetic drug substance.. .
Oulun Yliopisto



Anesthetic topics:
  • Anesthetic
  • Anesthesia
  • Anesthetics
  • Pharmaceutically Acceptable Salt
  • Drug Delivery System
  • Local Anesthesia
  • Phase Shift
  • Phase Change Material
  • Evaporation
  • Motor Function
  • Acute Pain
  • Ultrasound
  • Physiological Conditions
  • Physiologic
  • Cosmetic Procedure


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Anesthetic for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Anesthetic with additional patents listed. Browse our RSS directory or Search for other possible listings.


    0.1688

    file did exist - file did put2565

    5 - 1 - 54